🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

RecruitingNAAges 18 Years - 49 YearsFemaleChinese University of Hong Kong
NCT07006987 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Females aged 18 to 49 with mild to severe symptoms of pelvic pain and/or abnormal bleeding. * Diagnostic laparoscopy is scheduled with histology on any visually suspected endometriosis, and all reports (surgical and pathology) to confirm a positive result. If no visually suspicious endometriotic lesions are seen, biopsies from random areas during the laparoscopy procedure to confirm a negative histopathology result. * Blood drawn during secretory or proliferative phase of the menstrual cycle * Provide written informed consent to participate in the study and provide medical history on medications. Exclusion Criteria: * Patients who object to medical history collection and data requests * Patients with cancer and/or undergoing chemotherapy and/or radiotherapy * Patients who are unable or do not undergo laparoscopic surgery * Patients participating in additional interventional clinical studies * Pregnant, lactating, or subjects who are not healthy enough for blood donation. * Blood drawn during menses or ovulation phase of menstrual cycle * Females who are post-menopausa
💊

What it tests

  • A non-invasive blood-based (HerResolve)
📍

Where

1 site
Department of Obstetrics & Gynaecology The Chinese University of Hong Kong
Hong Kong, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy